Prediction of Sepsis After Percutaneous Nephrolithotomy
A Pre-operative Nomogram for Sepsis After Percutaneous Nephrolithotomy Treating Solitary, Unilateral, and Proximal Ureteral Stones
1 other identifier
observational
745
1 country
1
Brief Summary
We aim to determine the preoperative predictors of sepsis after percutaneous nephrolithotomy (PCNL) in patients with unilateral, solitary and proximal ureteral stones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2020
CompletedFirst Submitted
Initial submission to the registry
April 7, 2020
CompletedFirst Posted
Study publicly available on registry
April 9, 2020
CompletedApril 9, 2020
April 1, 2020
10 months
April 7, 2020
April 7, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
sepsis
the concurrence of infection and a minimum of two of the following within 48 hours of surgery: (1) heart rate \>90/minute, (2) body temperature \>38°C, (3) leukocyte count \<4,000 cells/μL or \>12,000 cells/μL, and (4) respiratory rate \>20/minute
within 48 hour after surgery
Study Arms (1)
proximal ureteral stone patient
Patients underwent percutaneous nephrolithotomy treating unilateral, solitary and proximal ureteral stones.
Interventions
percutaneous surgery using nephroscope
Eligibility Criteria
A total of 745 patients who underwent PCNL from January 2012 to December 2018 were enrolled when meeting eligibility criteria
You may qualify if:
- (1) PCNL was performed to treat unilateral, solitary, and proximal ureteral stones; and (2) age ≥18 years
You may not qualify if:
- anatomical renal abnormalities (horseshoe kidney, solitary kidney, transplant kidney and kidney duplication)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tongji Hospitallead
Study Sites (1)
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 7, 2020
First Posted
April 9, 2020
Study Start
March 1, 2019
Primary Completion
January 1, 2020
Study Completion
February 20, 2020
Last Updated
April 9, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share
The data is not suitable to be public